Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Finance
Nouryon readies for stock market listing
by Alex Scott
September 10, 2021
| A version of this story appeared in
Volume 99, Issue 33
Just 3 years after being purchased from AkzoNobel by the investment firms the Carlyle Group and GIC for $11.6 billion, Nouryon has announced plans to offer shares on the New York Stock Exchange. The Dutch specialty chemical maker has yet to disclose the number of shares or the planned price per share. The firm intends to use money from the share offering to pay down debt and meet other corporate requirements. Nouryon’s annual sales will be about $4.5 billion after the spin-off of its base-chemical unit.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X